Company Financials

Agios Pharmaceuticals, Inc. Financials

United States dollar

business Agios Pharmaceuticals, Inc. Company Profile

Main Stock Listing

NASDAQ: AGIO

Market Capitalization $1.58 Billion as of Jan. 1, 2026

Market Cap History

Valuations Metrics as of Jan. 3, 2026

Trailing PE 3.82
Forward PE -4.22
Price to Sales TTM $35.39
Price to Book MRQ $1.23
Enterprise to Revenue 15.11
Enterprise to EBITDA -1.44

Financial Reports as of Sep. 30, 2025

Financials

Fiscal Year Ends 2024-12-31
Most Recent Quarter 2025-09-30
Profit Margin 88.59%
Operating Margin -907.37%
Return on Assets TTM -18.71%
Return on Equity TTM -27.57%

Income Statement

Revenue TTM $44,791,000
Revenue per Share TTM $0.78
Quarterly Revenue Growth 43.70%
Gross Profit TTM $-295,224,000
EBITDA $-470,312,992
Net Income to Common TTM $-401,264,992
Diluted EPS TTM $-7.01
Quarterly Earnings Growth YoY 43.69%

Balance Sheet

Total Cash MRQ $952,860,032
Total Cash per Share MRQ $16.34
Total Debt MRQ $
Total Debt to Equity MRQ 3.47
Current Ratio MRQ 13.82
Book Value per Share MRQ $22.04

Cash Flow

Operating Cash Flow TTM $-409,931,008
Levered Free Cash Flow TTM $-313,977,376

AGIO Stock Info as of Jan. 3, 2026

Stock Statistics

Shares Outstanding 58,279,876
Float Shares 51,551,742
Avg 10 Volume 2,020,720
Avg 30 Volume None
Shares Short 6,126,003
Short Ratio 2.29
Short % of Shares 10.58%
% Held by Insiders 1.68%
% Held by Institutions 104.49%

Stock Price Summary

Beta 0.87
Fifty Two Week Low $22.24
Fifty Two Week High $46.00
Fifty Two Week Change -23.40%
Day 50 MA $33.37
Day 200 MA $34.21

Dividends and Splits

Forward Annual Dividend Rate $
Forward Annual Dividend Yield %
Trailing Annual Dividend Rate $0.00
Trailing Annual Dividend Yield 0.00%
Payout Ratio 0.00%
Dividend Date
Ex Dividend Date
Last Split Factor
Last Split Date